MedsFacts Meta-Analysis covering adverse side effect reports of INSULINA SIMPLES patients who developed MALIGNANT NEOPLASM PROGRESSION.
Introduction: MedsFacts provides MD-approved analysis to help both patients and physicians accurately research and assess the risk-reward trade off for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration, social media, and MedsFacts user submissions. Between January 2004 and October 2012, 4 individuals taking INSULINA SIMPLES reported MALIGNANT NEOPLASM PROGRESSION to the FDA. A total of 16 INSULINA SIMPLES drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.
Topics covered: This page is designed to help you determine the relationship, if any, between INSULINA SIMPLES and MALIGNANT NEOPLASM PROGRESSION. In doing so, we compare INSULINA SIMPLES with other drugs that cause MALIGNANT NEOPLASM PROGRESSION, to help you evaluate whether or not INSULINA SIMPLES causes MALIGNANT NEOPLASM PROGRESSION. Likewise, this page shows the most highly-reported side effects of INSULINA SIMPLES, so you can see if MALIGNANT NEOPLASM PROGRESSION ranks among INSULINA SIMPLES's most well-known side effects.
The Dashboard explained: The Dashboard first shows general Summary Statistics for INSULINA SIMPLES and MALIGNANT NEOPLASM PROGRESSION, such as the raw number and percentage of patients in FDA reports who used INSULINA SIMPLES and developed MALIGNANT NEOPLASM PROGRESSION. Next, the Dashboard lists the most common reasons (indications) why INSULINA SIMPLES was prescribed for patients. We then display a pie-chart which shows, in aggregate, what we believe represents general physician opinion of the safety of INSULINA SIMPLES. This pie-chart summarizes, for all FDA reports covering INSULINA SIMPLES, whether or not the treating physician felt INSULINA SIMPLES (versus other drugs the patient was taking) was responsible for the adverse side-effects. After the pie-chart, we itemize the most common side effects in FDA studies covering INSULINA SIMPLES. You may click on any of these side effects to learn more about them, in general, or specifically for INSULINA SIMPLES. Finally, we identify the drugs most widely associated with INSULINA SIMPLES in FDA literature. You may also click on any of these drugs to view it's dashboard.
Reports of INSULINA SIMPLES causing MALIGNANT NEOPLASM PROGRESSION: 4
Reports of any side effect of INSULINA SIMPLES : 16
Percentage of INSULINA SIMPLES patients where MALIGNANT NEOPLASM PROGRESSION is a reported side effect: 25%
FDA reports of any drug causing MALIGNANT NEOPLASM PROGRESSION : 13496
Average percentage for all medicated patients where MALIGNANT NEOPLASM PROGRESSION is reported as a complication: 0.084584961162429%
Most frequent diagnoses/indications for prescribing INSULINA SIMPLES:
DIABETES MELLITUS ( 4 patients )
( 0 patients )
Physician opinion on INSULINA SIMPLES as adverse event culprit:
Twitter feed for INSULINA SIMPLES - Pending/Beta
Drugs with high reportage of MALIGNANT NEOPLASM PROGRESSION:
ZOMETA (1675 patients)
GLEEVEC (1051 patients)
GEMZAR (884 patients)
DEXAMETHASONE (774 patients)
AREDIA (753 patients)
CISPLATIN (740 patients)
THALOMID (730 patients)
DECADRON (725 patients)
OXYCONTIN (714 patients)
CAPECITABINE (689 patients)
Basic reports are available, free of charge, in PDF format and are suitable for scientific publication. Further data and analytics are available upon request. We are in the process of adding new features to our site, including Q&A interface for patients to speak with experts on medication. Check back with us again in the near future to see.